Observational studyBreast cancer (Tokyo, Japan)2022

Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients.

C S Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.